GFAP, a common marker of astroglia, was generally elevated in rodents and humans during ageing [37], which indicates a potential marker of cognitive impairment induced by ageing [38], AD [39], heart failure [40] and type 2 diabetes [41]. This evidence concerns the gene GFAP and type 2 diabetes mellitus.